Papillomavirus Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-02-07
Clinical Trial Update: Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR) [Phase 4]
A Phase 4 clinical trial evaluates the efficacy of combining GLIZIGEN oral solution once daily with a vaginal gel nightly over 2 months in p…
CLINICAL_TRIALS trial_result · 2019-12-12
Clinical Trial Update: Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine. [Phase 2]
Phase 2 trial update for a novel HPV vaccine from GlaxoSmithKline assessing immunogenicity and safety in young adult women.
CLINICAL_TRIALS trial_result · 2017-03-17
Clinical Trial Update: Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation. [Phase 3]
Phase 3 trial update assessing immune responses of GSK's HPV vaccine after manufacturing process adaptation; results posted.
CLINICAL_TRIALS trial_result · 2016-03-28
Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females [Phase 3]
Phase 3 trial comparing HPV vaccines under alternative 2-dose schedules in 9-14 year-old females, focusing on immunogenicity and safety; com…
CLINICAL_TRIALS trial_result · 2015-05-08
Clinical Trial Update: Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old [Phase 3]
Phase 3 trial assessing safety and immunogenicity of GSK's HPV-16/18 L1 VLP AS04 vaccine (GSK-580299) in healthy girls 4-6 years old; study …
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2011-04-27
Clinical Trial Update: Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects. [Phase 3]
Phase 3 trial evaluating long-term immunogenicity and safety of an HPV vaccine in healthy female subjects has completed with results posted …
CLINICAL_TRIALS trial_result · 2009-12-21
Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age [Phase 3]
Phase 3 trial update reporting immunogenicity and safety of GSK HPV vaccine in healthy Japanese girls aged 10-15; study completed with resul…
CLINICAL_TRIALS trial_result · 2009-12-18
Clinical Trial Update: Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299) [Phase 3]
Phase 3 trial assessing immunogenicity and safety of co-administering a commercially available vaccine with the GSK HPV vaccine.